CMS announced a final rule on November 5, 2026 establishing a permanent framework for the Medicare Drug Price Negotiation Program and related Part D policies. According to the agency, the rule is intended to support durable prescription drug savings for Medicare beneficiaries while setting longer-term operating rules for the program. The action focuses on negotiated drug pricing and Part D administration rather than broader provider payment policy.
